Pfizer Celebrex Continued Marketing Supported By FDA Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
Committee finds celecoxib has cardiovascular side effects but may be safer than some other COX-2 inhibitors. Cardiovascular events may occur only at higher doses used for non-arthritis patients, some committee members suggest.